Skip to main content
Log in

Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The anti-platelet drug clopidogrel has been shown to modulate adhesion molecule and cytokine expression, both playing an important role in the pathogenesis of atherosclerosis. The aim of this study was to investigate the impact of clopidogrel on the development and progression of atherosclerosis. ApoE−/− mice fed an atherogenic diet (cholesterol: 1 %) for 6 months received a daily dose of clopidogrel (1 mg/kg) by i.p. injection. Anti-platelet treatment was started immediately in one experimental group, and in another group clopidogrel was started 2 month after beginning of the atherogenic diet. Blood was analysed at days 30, 60 and 120 to monitor the lipid profile. After 6 months the aortic arch and brachiocephalic artery were analysed by Sudan IV staining for plaque size and by morphometry for luminal occlusion. Serum levels of various adhesion molecules were investigated by ELISA and the cellular infiltrate was analysed by immunofluorescence. After daily treatment with 1 mg/kg clopidogrel mice showed a significant reduction of atherosclerotic lesions in the thoracic aorta and within cross sections of the aortic arch [plaque formation 55.2 % (clopidogrel/start) vs. 76.5 % (untreated control) n = 8, P < 0.05]. After treatment with clopidogrel P-/E-selectin levels and cytokine levels of MCP-1 and PDGFβ were significantly reduced as compared to controls. The cellular infiltrate showed significantly reduced macrophage and T-cell infiltration in clopidogrel-treated animals. These results show that clopidogrel can effectively delay the development and progression of ‘de-novo’ atherosclerosis. However, once atherosclerotic lesions were already present, anti-platelet treatment alone did not result in reverse remodelling of these lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ADP:

Adenosine diphosphate

OCT:

Optimal cutting temperature

DC:

Dendritic cells

References

  1. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038):1329–1339

    Article  Google Scholar 

  2. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E (2005) Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352(12):1179–1189

    Article  CAS  PubMed  Google Scholar 

  3. Ohkubo K, Fujimoto Y, Iwata Y, Kitahara H, Kadohira T, Sugimoto K, Morino T, Kobayashi Y (2014) Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels 29(1):1–6

    Article  PubMed  Google Scholar 

  4. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196(7):887–896

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J, Gawaz M (2005) Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112(8):1180–1188

    Article  CAS  PubMed  Google Scholar 

  6. Herbert JM (2004) Effects of ADP-receptor antagonism beyond traditional inhibition of platelet aggregation. Expert Opin Investig Drugs 13(5):457–460

    Article  CAS  PubMed  Google Scholar 

  7. Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006) No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease. Thromb Haemost 96(5):660–664

    CAS  PubMed  Google Scholar 

  8. Azar RR, Kassab R, Zoghbi A, Aboujaoude S, El-Osta H, Ghorra P, Germanos M, Salame E (2006) Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease. Am Heart J 151(2):521 e521–521 e524

    Article  Google Scholar 

  9. Abele S, Spriewald BM, Ramsperger-Gleixner M, Wollin M, Hiemann NE, Nieswandt B, Weyand M, Ensminger SM (2009) -A35) Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts. Transplantation 87(2):207–216

    Article  CAS  PubMed  Google Scholar 

  10. Eckl S, Heim C, Abele-Ohl S, Hoffmann J, Ramsperger-Gleixner M, Weyand M, Ensminger SM (2010) Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts. Transpl Int 23(9):959–966

    CAS  PubMed  Google Scholar 

  11. Heim C, Eckl S, Gebhardt J, Weyand M, Ensminger SM (2010) Die unterschätzte Rolle von Thrombozyten bei der Herztransplantation. Zeitschrift für Herz-, Thorax- und Gefäßchirurgie 24(4):241–250

    Article  Google Scholar 

  12. Rathouska J, Nemeckova I, Zemankova L, Strasky Z, Jezkova K, Varejckova M, Nachtigal P (2015) Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis. Heart Vessels 30(2):241–248

    Article  PubMed  Google Scholar 

  13. Afek A, Kogan E, Maysel-Auslender S, Mor A, Regev E, Rubinstein A, Keren G, George J (2009) Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvasc Res 77(3):364–369

    Article  CAS  PubMed  Google Scholar 

  14. Schulz C, Konrad I, Sauer S, Orschiedt L, Koellnberger M, Lorenz R, Walter U, Massberg S (2008) Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo. Thromb Haemost 99(1):190–195

    CAS  PubMed  Google Scholar 

  15. Abele S, Weyand M, Wollin M, Hiemann NE, Harig F, Fischlein T, Ensminger SM (2006) Clopidogrel reduces the development of transplant arteriosclerosis. J Thorac Cardiovasc Surg 131(5):1161–1166

    Article  CAS  PubMed  Google Scholar 

  16. Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N, Heusinger-Ribeiro J, Atzler D, Strobel J, Schwedhelm E, Boger RH, Hilgers KF (2010) Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine. Am J Pathol 176(5):2559–2570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ensminger SM, Billing JS, Morris PJ, Wood KJ (2000) -E18) Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse. J Heart Lung Transplant 19(11):1039–1046

    Article  CAS  PubMed  Google Scholar 

  18. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14(1):33–43

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Nishiyama T, Mishima K, Obara K, Inoue H, Doi T, Kondo S, Saka M, Tabunoki Y, Hattori Y, Kodama T, Tsubota K, Saito I (2007) Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjogren’s syndrome model mice. Clin Exp Immunol 149(3):586–595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yamamoto T, Nakahata Y, Tanaka M, Yoshida M, Soma H, Shinohara K, Yasuda A, Mamine T, Takumi T (2005) Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element. J Biol Chem 280(51):42036–42043

    Article  CAS  PubMed  Google Scholar 

  21. Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233–241

    CAS  PubMed  Google Scholar 

  22. Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340(2):115–126

    Article  CAS  PubMed  Google Scholar 

  23. Kher N, Marsh JD (2004) Pathobiology of atherosclerosis–a brief review. Semin Thromb Hemost 30(6):665–672

    Article  CAS  PubMed  Google Scholar 

  24. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378–3384

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moura R, Tjwa M, Vandervoort P, Van Kerckhoven S, Holvoet P, Hoylaerts MF (2008) Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE−/− mice. Circ Res 103(10):1181–1189

    Article  CAS  PubMed  Google Scholar 

  26. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12(2):178–180

    Article  CAS  PubMed  Google Scholar 

  27. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27(4):893–900

    Article  CAS  PubMed  Google Scholar 

  28. Heim C, Eckl S, Preidl R, Ramsperger-Gleixner M, Koch N, Goldmann K, Spriewald BM, Weyand M, Ensminger SM (2015) Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts. Eur J Cardiothorac Surg 47(1):180–187

    Article  PubMed  Google Scholar 

  29. Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101(7):2661–2666

    Article  CAS  PubMed  Google Scholar 

  30. Li G, Sanders JM, Bevard MH, Sun Z, Chumley JW, Galkina EV, Ley K, Sarembock IJ (2008) CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 172(4):1141–1152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lindemann S, Kramer B, Seizer P, Gawaz M (2007) Platelets, inflammation and atherosclerosis. J Thromb Haemost 5(Suppl 1):203–211

    Article  CAS  PubMed  Google Scholar 

  32. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelsberger H, Langenbrink K, Page S, Neumeier D, Schomig A, Brand K (1998) Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98(12):1164–1171

    Article  CAS  PubMed  Google Scholar 

  33. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255–1262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394(6696):894–897

    Article  CAS  PubMed  Google Scholar 

  35. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874

    Article  CAS  PubMed  Google Scholar 

  36. Wood KJ, Goto R (2012) Mechanisms of rejection: current perspectives. Transplantation 93(1):1–10

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicting financial interests, research support was obtained from the ELAN and IZKF -trust of the University of Erlangen-Nuernberg and the ADUMED-foundation, and no other funding source was employed.

Ethical standard

The study protocol was approved by the local animal research ethics committee and was conducted in accordance with the Helsinki Declaration.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Heim.

Additional information

C. Heim and J. Gebhardt have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heim, C., Gebhardt, J., Ramsperger-Gleixner, M. et al. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heart Vessels 31, 783–794 (2016). https://doi.org/10.1007/s00380-015-0696-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-015-0696-7

Keywords

Navigation